Trade Bristol Myers ^BMY

Bank of America Says the Fed Should Raise Rates Now: 4 Dividend Inflation-Resistant Stocks

Bristol Myers Squibb (BMY) Wins FDA Filing And Nvidia Tie Up, Is It Still Undervalued?

First Trust Advisors LP Raises Position in Bristol Myers Squibb Company $BMY

Bellwether Advisors LLC Purchases New Shares in Bristol Myers Squibb Company $BMY

Alexandria Real Estate Equities (ARE) Delivers 427,000 RSF Bristol Myers Squibb R And D Hub

Westpac Banking Corp Has $11.68 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Novartis (SWX:NOVN) Is Pushing AI Deeper Into Drug Discovery

Bellwether Advisors LLC Acquires New Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells

Independent Financial Group LLC Invests $976,000 in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Acquires Nvidia's Advanced AI System for Faster Drug Discovery, ETManufacturing

Bristol Myers Squibb Company $BMY Shares Bought by Meeder Asset Management Inc. - Stock Observer

HORAN Wealth LLC Grows Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Erste Group Bank Has Positive Outlook of BMY FY2026 Earnings - Stock Observer

Epicardial adipose tissue thickness is associated with circulating biomarkers in individuals without known cardiac disease across a broad adiposity spectrum

Bristol Myers Expands NVIDIA Partnership to Build Top Life Sciences AI Supercomputer

Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory

Bristol Myers Squibb (BMY) Doubles Down on Nvidia (NVDA) AI Tech for Drug Development

Nvidia partners with Bristol-Myers Squibb to build AI supercomputer for drug discovery

Bristol Myers buys Nvidia's latest AI computing system for drug research

Pharmaceutical Stocks To Research - July 20th - Daily Political

Bristol Myers (BMY) Is Up 5.5% After FDA Accepts Mezigdomide NDA In Multiple Myeloma

Swiss National Bank Raises Stock Position in Bristol Myers Squibb Company $BMY - Markets Daily

SEB Asset Management AB Takes Position in Bristol Myers Squibb Company $BMY

Mediolanum International Funds Ltd Has $82.85 Million Holdings in Bristol Myers Squibb Company $BMY

Swiss National Bank Purchases 396,700 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

FDA-Approved PD-L1 Test for GI Cancers Could Be A Game Changer For Agilent Technologies (A)

Hillsdale Investment Management Inc. Has $101,000 Holdings in Bristol Myers Squibb Company $BMY

California Public Employees Retirement System Purchases 121,813 Shares of Bristol Myers Squibb Company $BMY

Allspring Global Investments Holdings LLC Boosts Stake in Bristol Myers Squibb Company $BMY

SteelPeak Wealth LLC Has $1.62 Million Stock Position in Bristol Myers Squibb Company $BMY - Daily Political

Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from a large single-centre cohort analysis

Bristol Myers Squibb Company $BMY Shares Purchased by Geneos Wealth Management Inc. - Markets Daily

Is Bristol-Myers Squibb (BMY) Reasonable After Its 32% Run?

Aware Super Pty Ltd as trustee of Aware Super Purchases New Shares in Bristol Myers Squibb Company $BMY - Daily Political

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Investors Purchase High Volume of Call Options on Bristol Myers Squibb (NYSE:BMY) - Zolmax

Investors Buy Large Volume of Bristol Myers Squibb Call Options (NYSE:BMY)

Illinois Municipal Retirement Fund Sells 87,210 Shares of Bristol Myers Squibb Company $BMY

Bank of New York Mellon Corp Sells 1,194,538 Shares of Bristol Myers Squibb Company $BMY

Response kinetics and depth of response after idecabtagene vicleucel in relapsed/refractory multiple myeloma

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results

Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada | Morningstar

Diversify Wealth Management LLC Acquires 21,775 Shares of Bristol Myers Squibb Company $BMY

Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada | Valuespectrum.com

Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 - Data Talk | Morningstar

Bristol Myers Squibb (BMY) Following FDA Acceptance Has An Undervalued Case

Juvenile Idiopathic Arthritis Market is Forecast to Grow at a 4.6% CAGR from 2026 to 2036 As Biologics, JAK Inhibitors, and Emerging Targeted Therapies Reshape Pediatric Arthritis Treatment.

Real-world treatment patterns, healthcare resource utilization and economic burden in U.S. adults with schizophrenia with and without tardive dyskinesia

Single-cell transcriptome reveals keratinocyte subclusters contributing to altered differentiation and inflammatory responses in atopic dermatitis

Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight

Bristol Myers Wins FDA Review of Mezigdomide in Multiple Myeloma | Morningstar

Global consortium releases AI toolbox to unlock new Alzheimer's treatments

An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial

Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages

Kestra Advisory Services LLC Increases Holdings in Bristol Myers Squibb Company $BMY

Castleview Partners LLC Sells 11,554 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

KLCM Advisors Inc. Sells 19,755 Shares of Bristol Myers Squibb Company $BMY

Candriam S.C.A. Cuts Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Conning Inc.

Did FTSE Russell's Reclassification and Dividend Streak Just Shift Bristol-Myers Squibb's (BMY) Investment Narrative?

Bristol Myers Squibb (NYSE:BMY) Price Target Cut to $66.00 by Analysts at Bank of America

Bank of America Issues Pessimistic Forecast for Bristol Myers Squibb (NYSE:BMY) Stock Price - Stock Observer

Summit Securities Group LLC Sells 82,290 Shares of Bristol Myers Squibb Company $BMY

U.S. House committee investigates pharmaceutical giants for clinical trials at Chinese military hospitals - NaturalNews.com

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial

The PRECISE European initiative for cancer-vulnerability mapping and prediction

Associations of plasma MMP-9 and MPO with functional outcome in moderate to severe acute ischemic stroke

Connective Tissue Disease Associated with Interstitial Lung Disease Market Report, Details Drug Class Breakdown Across Corticosteroids, Antifibrotics, Immunosuppressants, and Biologics

Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight

Bristol-Myers Squibb's Q2 2026 Earnings: What to Expect

R Squared Ltd Sells 17,443 Shares of Bristol Myers Squibb Company $BMY - Zolmax

Burney Co. Trims Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Sumitomo Mitsui Trust Group Inc. - Daily Political

Merck & Company (MRK) Gets a Buy from RBC Capital

Bristol Myers Squibb names Singapore as new Pan Asia Hub

Swedbank AB Has $179.63 Million Stake in Bristol Myers Squibb Company $BMY - Zolmax

Walser Wealth Management Company A Ltd Liability Co Invests $592,000 in Bristol Myers Squibb Company $BMY - Stock Observer

Swedbank AB Sells 17,734 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Quantifying cortical lesions in multiple sclerosis MRI datasets using multi-contrast post-processing and deep learning

PFG Investments LLC Sells 10,347 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

PFG Investments LLC Has $2.82 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Hudson Edge Investment Partners Inc. Has $8.42 Million Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumab

Keybank National Association OH Raises Holdings in Bristol Myers Squibb Company $BMY

Strs Ohio Sells 32,917 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Acquired by Keybank National Association OH - Stock Observer

Bristol Myers Squibb Company $BMY Shares Acquired by Counterpoint Mutual Funds LLC - Stock Observer

Tumor Microenvironment Modulation Market to Hit USD 3.73 Billion by 2031 with a 7.4% CAGR - Key Trends and Insights

BMY's Shift Into Russell Value Defensive Indexes Might Change The Case For Investing In Bristol-Myers Squibb (BMY)

Bristol Myers Squibb Company $BMY Shares Sold by Pzena Investment Management LLC

Bristol Myers Squibb Company $BMY Stock Position Lowered by iA Global Asset Management Inc.

Bristol Myers Squibb Company $BMY Shares Sold by iA Global Asset Management Inc.

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years